Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Jun 23, 2021 2:03pm
168 Views
Post# 33435233

RE:I am a bit bipolar

RE:I am a bit bipolarAfter SPCEO1 before, this is the seconf similar message about how a small Canadian company could be behind something potentially big? I understand why one would think that, but at the same time, don't wonder why the stock price is not moving up. The skepticism is even among shareholders!!!

Also, I would add this question to yours: How could it be that FDA gave TH1902 fast track designation while the drug was still at the preclinical stage? I think this is a good question to meditate about...

Contrary to potential investors, FDA had access to the full preclinical data. So there must be a reason why the gave the fast track designation. It does not make it a sure thing, but it surely proves that there are serious reasons to be positive about the outcome.

stockman75 wrote: As I watched the webinar and saw all the impressive pre-clinical results and then after reading all the posts over time from the very knowledgable folks on this message board.... 

I have concluded I am quite bipolar when it comes to the cancer program. On the one hand it is all quite impressive and seems like there is a high probability there is somehting quite massive in the works. 

On the other hand I think to myself how could it be little Thera a small canadian bio-tech could be on to a major advancement in cancer treatment. How could it be Katana sold for next to nothing? How could it be that big pharma did not pick this up? How could it be that it does not get more exposure? The list goes on in the how can it be and I conclude (at that moment of bipolarness) most likely we will not see anywhere near the preclincal results. There has to be a catch..

I know many posts so far have addressed some of these questions/concepts but I still remain bipolar. One moment I think wow this is amazing and exciting. Not just from a potential financial reward perspective but the from the aspect that this is a pretty big breakthough for cancer treatment and what this could mean for people with cancer. and that it all is coming from little bio-tech in canada. Now I know that the wise folks on the science side (and even finance side) say there is much to prove and still considerable risk that it fails in the complex human body. I get that but wow if it works somewhat close to the results in pre-clinical it will be pretty amazing. But again in the back of my mind are all those questions how can this be without anyone seeming to notice except for some people on a public message board and a few institutions. Again bipolar. Am I going crazy?!  

By the way thank you to all who have extensive knowledge on the science and finances and contribute so much information. It is truly appreciated and I wish I could add just a small amount of info compared to your frequent and knowledgeable posts. So anyway thank you all even though I know some of you don't want to tolerate the neohphytes who aren't as knowledgeable or scientific minded etc. Yes I have no problem admitting my own ignorance. :-)




<< Previous
Bullboard Posts
Next >>